{"url_path":"/sec/ser/8-k/2026-06-24/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-24","source_url":"https://www.sec.gov/Archives/edgar/data/1708599/0001708599-26-000040-index.html","accession_number":"0001708599-26-000040","cik":"0001708599","ticker":"SER","issuer_name":"Serina Therapeutics, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1708599/0001708599-26-000040-index.html","primary_entity_key":"0001708599","primary_entity_name":"Serina Therapeutics, Inc."},"word_count":98,"has_tables":true,"body_markdown":"Item 9.01 - Financial Statements and Exhibits.\n\n(d) Exhibits\n\nExhibit\nNumberDescription\n\n3.1\n[First Certificate of Amendment to the First Amended and Restated Certificate of Incorporation of Serina Therapeutics, Inc.,](serina-firstcertificateofa.htm)[dated](serina-firstcertificateofa.htm)[June 17, 2026.](serina-firstcertificateofa.htm)\n\n10.1\n[First Amendment to the Serina Therapeutics, Inc. 2024 Equity Incentive Plan.](serina-amendmentto2024equi.htm)\n\n104Cover Page Interactive Data File (embedded within the Inline XBRL document)\n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\nSERINA THERAPEUTICS, INC.\n\nDate: June 24, 2026\nBy:/s/ Steve Ledger\n\nChief Executive Officer"}